LTIP1970A - Composition for ophthalmic use - Google Patents

Composition for ophthalmic use

Info

Publication number
LTIP1970A
LTIP1970A LTIP1970A LTIP1970A LTIP1970A LT IP1970 A LTIP1970 A LT IP1970A LT IP1970 A LTIP1970 A LT IP1970A LT IP1970 A LTIP1970 A LT IP1970A LT IP1970 A LTIP1970 A LT IP1970A
Authority
LT
Lithuania
Prior art keywords
composition
ophthalmic use
ophthalmic
Prior art date
Application number
LTIP1970A
Inventor
Arto Urtti
Tomi Jaervinen
Pekka Suhonen
Kari Lehmussaari
Timo Reunamaeki
Sakari Alaranta
Olli Oksala
Esko Pohjala
Hannu Hanhijaervi
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of LTIP1970A publication Critical patent/LTIP1970A/en
Publication of LT3525B publication Critical patent/LT3525B/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTIP1970A 1993-06-24 1994-06-23 Composition for ophthalmic use LT3525B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9302203A SE501482C2 (en) 1993-06-24 1993-06-24 Composition for topical administration of bispilocarpic acid diesters to the eye in the form of an aqueous solution

Publications (2)

Publication Number Publication Date
LTIP1970A true LTIP1970A (en) 1995-01-31
LT3525B LT3525B (en) 1995-11-27

Family

ID=20390417

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1970A LT3525B (en) 1993-06-24 1994-06-23 Composition for ophthalmic use

Country Status (5)

Country Link
AU (1) AU6973194A (en)
EE (1) EE9400040A (en)
LT (1) LT3525B (en)
SE (1) SE501482C2 (en)
WO (1) WO1995000144A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2192965C (en) * 1994-07-11 2007-12-04 David W. Pate Anandamide analogue compositions and method of treating intraocular hypertension using same
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2023225113A1 (en) * 2022-05-18 2023-11-23 Bexson Biomedical, Inc. Complexing agent salt formulations of pharmaceutical compounds at low stoichiometric ratios

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58126810A (en) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd Ophthalmic anti-inflammatory solution and preparation thereof
TW200402B (en) * 1990-08-13 1993-02-21 Senju Pharma Co
FI98815C (en) * 1990-11-30 1997-08-25 Santen Oy Process for the preparation of new pharmacologically useful ester derivatives of bispilocarpic acid

Also Published As

Publication number Publication date
SE9302203D0 (en) 1993-06-24
SE501482C2 (en) 1995-02-27
SE9302203L (en) 1994-12-25
AU6973194A (en) 1995-01-17
WO1995000144A1 (en) 1995-01-05
EE9400040A (en) 1995-12-15
LT3525B (en) 1995-11-27

Similar Documents

Publication Publication Date Title
IL115479A0 (en) Composition for ophthalmic use
IL111517A0 (en) Ophthalmic formulation
GB9318841D0 (en) Composition
GB2302018B (en) Ophthalmic pharmaceutical composition
GB9302130D0 (en) Cleasing composition
ZA924974B (en) Ophthalmic compositions
GB9313274D0 (en) Composition
GB9312204D0 (en) Therapeutic composition
GB9308286D0 (en) Tonometer
IL103907A0 (en) Ophthalmic compositions
GB2281914B (en) Composition
LTIP1970A (en) Composition for ophthalmic use
GB9311423D0 (en) New use
ZA946967B (en) Lyophillisate composition
AU6973094A (en) Composition for ophthalmic use
GB2282385B (en) Composition
GB9320370D0 (en) Frit-containing composition
LTIP1969A (en) Composition for ophthalmic use
ZA958488B (en) Composition for ophthalmic use
GB9320598D0 (en) Composition
GB9309179D0 (en) New use
ZA94858B (en) Composition for agricultural use
GB9317061D0 (en) Composition
GB9307790D0 (en) Composition
GB9318548D0 (en) Composition

Legal Events

Date Code Title Description
PC9A Transfer of patents

Free format text: SANTEN OY,NIITTYHAANKATU 20, FIN-33720 TAMPERE,FI,971017

MM9A Lapsed patents

Effective date: 19990623